Work

Supplementary Figure S8 from Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non–Small Cell Lung Cancer Patient-Derived Tumor Organoids

Year: 2024
Type: supplementary-materials
Abstract: Supplementary Figure S8. Quantification of AKR1B10 expression in resistant and sensitive PDTOs and matched patient tumor tissues.
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4402200820
Cites:
Cited by:
Related to: 10